OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET
July 21, 2022 07:30 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., July 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership
June 23, 2022 07:30 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., June 23, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution
June 07, 2022 08:00 ET
|
OptimizeRx Corporation
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation...
OptimizeRx to Participate in Upcoming June Conferences
May 24, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 24, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100
May 17, 2022 10:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Authorizes $20 Million Share Repurchase Program
May 17, 2022 08:30 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Upcoming May Conferences
May 10, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
May 04, 2022 16:01 ET
|
OptimizeRx Corporation
Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer clientTraction with top 20 pharmaceutical manufacturers continues to advance and drive growthCash...
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
April 29, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., April 29, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET
April 21, 2022 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., April 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...